- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.03. | PACS Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.03. | PACS Group adds former CMS official Patrick Conway to board | 3 | Investing.com | ||
| PACS GROUP Aktie jetzt für 0€ handeln | |||||
| 02.03. | RBC Capital raises PACS Group stock price target on strong guidance | 3 | Investing.com | ||
| 27.02. | Truist raises PACS Group stock price target to $50 on margin strength | 3 | Investing.com | ||
| 27.02. | PACS Group GAAP EPS of $1.22, revenue of $5.29B | 10 | Seeking Alpha | ||
| 27.02. | PACS Group outlines 8% revenue growth target for 2026 as integration drives record year | 2 | Seeking Alpha | ||
| 26.02. | Earnings Summary: PACS Group Q4 | 1 | Benzinga.com | ||
| 26.02. | PACS Group, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 07.01. | RBC Capital reiterates Outperform rating on PACS Group stock | 1 | Investing.com | ||
| 19.12.25 | PACS Group stock price target raised to $47 from $33 at RBC Capital | 2 | Investing.com | ||
| 18.12.25 | PACS Group: UBS senkt Kursziel auf 42 US-Dollar, bleibt aber bei Kaufempfehlung | 1 | Investing.com Deutsch | ||
| 17.12.25 | PACS Group stock rating reinstated as Overweight by JPMorgan | 3 | Investing.com | ||
| 12.12.25 | Truist Securities hebt Kursziel für PACS Group auf 40 US-Dollar an | 1 | Investing.com Deutsch | ||
| 12.12.25 | PACS Group stock price target raised to $40 from $32 at Truist Securities | 1 | Investing.com | ||
| 01.12.25 | PACS Group, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.11.25 | PACS Group: Truist Securities bekräftigt "Buy"-Rating und Kursziel von 32 USD | 2 | Investing.com Deutsch | ||
| 20.11.25 | PACS Group stock rating reiterated at Buy by Truist Securities | 1 | Investing.com | ||
| 20.11.25 | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | 866 | AFX News | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 20.11.25 | RBC Capital raises PACS Group stock price target to $33 on strong Q3 results | 1 | Investing.com | ||
| 20.11.25 | RBC Capital hebt Kursziel für PACS Group nach starken Q3-Zahlen auf 33 $ an | 5 | Investing.com Deutsch |
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 39,650 | 0,00 % | Shortseller-Positionen aktuell: u.a. Carl Zeiss Meditec, Evonik, FMC, Gerresheimer, GFT, MTU, Nordex, Ströer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| MEDTRONIC | 74,90 | +0,24 % | Future Market Insights: Global Weight Loss and Obesity Management Market | 12.8% CAGR Growth Trajectory | Asia Pacific, North America Lead | Novo Nordisk, Eli Lilly, Medtronic Drive Integrated Care Evolution | NEWARK, Del., April 9, 2026 /PRNewswire/ -- According to the latest analysis by Future Market Insights, the global weight loss and obesity management market is undergoing a transformative... ► Artikel lesen | |
| M1 KLINIKEN | 15,060 | 0,00 % | M1 Kliniken schließt Verkauf von Haemato Pharm ab | Die M1 Kliniken AG hat den Verkauf der Haemato Pharm GmbH über ihre Mehrheitsbeteiligung Haemato AG an die Phoenix Group mit Wirkung zum Ablauf des 31. Januar 2026 abgeschlossen. Sämtliche Vollzugsbedingungen... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 54,37 | +0,46 % | Boston Scientific Corporation: Boston Scientific receives FDA clearance for the Asurys Fluid Management System | New technology designed to provide a single irrigation management system for ureteroscopy, cystoscopy, percutaneous nephrolithotomy (PCNL) and benign prostatic hyperplasia... ► Artikel lesen | |
| MCKESSON | 737,80 | +0,82 % | ALLZEITHOCH: EchoIQ bei 1$ AUD - der größte Trigger steht unmittelbar bevor | ||
| INSULET | 166,80 | -2,40 % | Insulet Corporation: Insulet to Present EVOLUTION 2 Results on Omnipod Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) | Fully Closed-Loop System Feasibility Study to be presented at Insulet Symposium and in e-Poster during ATTD 2026 Real World Evidence of Settings Optimization in Omnipod 5 Users will also... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,280 | +1,48 % | Alignment Healthcare (ALHC) Soars 16% on Medicare Reimbursement Hike | ||
| PROGYNY | 17,170 | +1,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ADAPTHEALTH | 12,770 | +3,65 % | AdaptHealth refinances $1.1B senior secured credit facility | ||
| BRIGHTSPRING HEALTH SERVICES | 46,040 | -0,04 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita | LOUISVILLE, Ky., March 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based pharmacy and... ► Artikel lesen | |
| HEARTFLOW | 29,020 | +5,68 % | Heartflow, Inc.: Heartflow Files Patent Infringement Lawsuit Against Cleerly | MOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 19,740 | +5,34 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner | ||
| BETA BIONICS | 11,815 | +11,04 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,120 | +0,43 % | What Makes Privia Health (PRVA) One of the Best Mid-Cap Growth Stocks to Invest in | ||
| LIFESTANCE HEALTH GROUP | 6,510 | +0,70 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |
PACS GROUP INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 33,130 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PACS GROUP INC finden Sie auf Wallstreet Online.